EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Immunoassay antibody modification significantly impacts low-dose dexamethasone suppression test cutoffs in dogs with Cushing syndrome

Giacomo Rossi, Francesca Del Baldo, Antonio Maria Tardo iD, Stefania Golinelli, Federico Fracassi iD

American Journal of Veterinary Research · 01.06.2026 · 87 (6)

DOI: 10.2460/ajvr.25.12.0451 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Veterinary Research, erschienen am 01.06.2026. Verfasst von Giacomo Rossi und 4 weiteren Autor:innen. Hauptthemen laut MEDLINE: Dog Diseases, Cushing Syndrome, Dexamethasone, Hydrocortisone. Die Arbeit nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To reassess the 8-hour postdexamethasone (T8) cortisol diagnostic cutoff for suspected naturally occurring Cushing syndrome (CS) in dogs comparing a chemiluminescent cortisol immunoassay (Immulite 2000 XPi; Siemens Healthineers) results before and after the 2020 antibody change.

Methods

Low-dose dexamethasone suppression test results were retrospectively evaluated in dogs with CS and in those with disease mimicking Cushing syndrome (DMCS), with sensitivity (Se), specificity (Sp), and receiver operating characteristic curves assessed. Cortisol concentrations after the antibody change were adjusted using the Siemens Healthineers conversion formula.

Results

61 dogs with CS and 32 with DMCS were included between January 2016 and October 2020 (old antibody [OA]). Forty dogs with CS and 40 with DMCS were included between November 2020 and January 2024 (new antibody [NA]). The area under the curve for T8 cortisol to differentiate CS from DMCS dogs was 0.96 (95% CI, 0.91 to 0.99) with OA and 0.96 (95% CI, 0.90 to 1.0) with NA. The cutoff associated with the best sensitivity and specificity to diagnose CS was > 35.9 nmol/L (1.3 μg/dL; Se = 88.9%, 95% CI, 78.4% to 95.4%; Sp = 96.9%, 95% CI, 83.8% to 99.9%) with OA and > 33.1 (1.2 μg/dL; Se = 92.5%, 95% CI, 79.6% to 98.4%; Sp = 95.0%, 95% CI, 83.08% to 99.4%) with NA.

Conclusions

The optimal cut point of the low-dose dexamethasone suppression test T8 cortisol for CS diagnosis after the antibody change was > 33.1 nmol/L (1.2 μg/dL), which is lower than the currently accepted cutoff of > 38.6 nmol/L (1.4 μg/dL). Clinical Relevance New cutoff value of T8 cortisol has been identified for the diagnosis of CS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dog DiseasesCushing SyndromeDexamethasoneHydrocortisoneAntibodiesAnimalsDogsFemaleImmunoassayRetrospective StudiesSensitivity and SpecificityMale

Stichwörter der Autor:innen

Cushing’s syndromeLDDSTantibodycutoffdiagnosis

Substanzen

DexamethasoneHydrocortisoneAntibodies

Autor:innen und Institutionen

ORCID-Profile: Antonio Maria Tardo, Federico Fracassi

Zitieren

APA

Rossi, G., Del Baldo, F., Tardo, A. M., Golinelli, S., & Fracassi, F. (2026). Immunoassay antibody modification significantly impacts low-dose dexamethasone suppression test cutoffs in dogs with Cushing syndrome. American Journal of Veterinary Research, 87(6). https://doi.org/10.2460/ajvr.25.12.0451

Vancouver

Rossi G, Del Baldo F, Tardo AM, Golinelli S, Fracassi F. Immunoassay antibody modification significantly impacts low-dose dexamethasone suppression test cutoffs in dogs with Cushing syndrome. American Journal of Veterinary Research. 2026;87(6). doi:10.2460/ajvr.25.12.0451

BibTeX
@article{Rossi2026,
  author = {Rossi, Giacomo and Del Baldo, Francesca and Tardo, Antonio Maria and Golinelli, Stefania and Fracassi, Federico},
  title = {Immunoassay antibody modification significantly impacts low-dose dexamethasone suppression test cutoffs in dogs with Cushing syndrome},
  journal = {American Journal of Veterinary Research},
  year = {2026},
  volume = {87},
  number = {6},
  doi = {10.2460/ajvr.25.12.0451}
}
Kostenlos starten →